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Subarachnoid hemorrhage may be complicated by
neurogenic stunned myocardium, a catecholamine-
induced transient cardiomyopathy that displays a wide
clinical spectrum of cardiac abnormalities, including
electrocardiographic changes, arrhythmias, myocardial
necrosis, and left ventricular systolic and diastolic
dysfunction. However, less is known about the cardiac
metabolic consequences of acute subarachnoid
hemorrhage. Prunet and coworkers’ recent study
provides scintigraphic evidence suggesting that glucose
metabolism and sympathetic cardiac innervation are
severely and globally depressed during the acute phase
of the disease. Metabolic and innervation abnormalities
are largely overlapped and are probably not causally
related to myocardial ischemia, suggesting that impaired
glucose metabolism is probably neurogenic in nature.
The scintigraphic defects seem to reverse slowly, within
months of the onset of cerebral bleeding. Interestingly,
scintigraphic evidence of metabolic myocardial
alterations may exist even in the absence of clinical
features of cardiac disease, possibly representing a
subclinical type of neurogenic stunned myocardium.These data provide novel insight into the metabolic conse-Subarachnoid hemorrhage (SAH) may cause transient
cardiac dysfunction, possibly attributed to massive release
of catecholamines. The influence of catecholamine overse-
cretion on cardiac metabolism has been extensively stud-
ied in Takotsubo cardiomyopathy (TTC), which is also
considered catecholamine induced in nature. However,
data regarding acute myocardial metabolic alterations
in SAH are sparse. The recent article by Prunet and* Correspondence: y_papanikolaou@hotmail.com
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studied area [1].
In their recent article, Prunet and coworkers assessed
myocardial glucose metabolism and sympathetic innerv-
ation in SAH by means of scintigraphy, and investigated
the possible associations with left ventricular (LV) sys-
tolic and diastolic dysfunction, troponin elevation and
SAH outcomes [1]. The authors provide scintigraphic
evidence of impaired glucose metabolism (assessed by 18
F-fluorodesoxyglucose positron emission tomography)
and sympathetic innervation (studied by 123I-meta-iodo-
benzylguanidine scintigraphy) in 83.3% (25/30) and 90%
(27/30), respectively, of 30 patients with acute SAH.
Despite extensive changes in glucose metabolism and
innervation, coronary perfusion was not affected. The
topography and extent of metabolic and innervation
scintigraphic defects were largely overlapped, supporting
the hypothesis that metabolic shifts occurred secondarily
to neurocardiogenic injury rather than cardiac ischemia
[2,3]. Follow-up studies showed improvement of glucose
metabolism in 50% (15/30) of SAH patients in 1 to
2 months. Normalization of sympathetic innervation was
slower, however; only 26.7% (8/30) exhibited normal 123I-
meta-iodobenzylguanidine scintigraphy 6 months later [1].
quences and their evolution over time in SAH, an issue
that was until now largely undetermined.
SAH-induced neurocardiogenic injury demonstrates
comparable scintigraphic features [4,5] with TTC, which
is also attributed to massive release of catecholamines
[6]. However, the topography of these regional abnormal-
ities differs significantly between SAH, which diffusely
affects LV myocardium [1], and TTC, in which LV apical
myocardium is predominantly affected [4,5]. Furthermore,
myocardial scintigraphic defects showed no association to
echocardiography in SAH [1], whereas impaired glucoseentral Ltd. The licensee has exclusive rights to distribute this article, in any medium,
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on echocardiography.
Although increased adrenergic tone has been accounted
for in both SAH and TTC [6], there might be several
factors that may explain, at least in part, potential differ-
ences in their scintigraphic, echocardiographic and clinical
manifestations. Such parameters might regard the cul-
prit catecholamines (directly released noradrenaline in
SAH versus circulating epinephrine in TTC) [7] and
the adrenoreceptors involved (β1-receptors in SAH versus
β2-receptors highly concentrated in the apex in TTC) [8],
the nature of myocyte injury (direct cardiotoxicity in SAH
[6] versus anti-apoptotic adaptation in TTC [8]), the pres-
ence of myocardial ischemia (not validated in SAH [1,9]
versus possibly impaired microcirculation in TTC [10]),
new polymorphisms and genetic causes of the sympathetic
nervous system overactivity [11].
What is remarkable in the study by Prunet and col-
leagues is not the detection of neurometabolic myocardial
alterations in SAH – such changes might probably be ex-
pected, since similar findings have been described in TTC.
No, what is remarkable is that regional scintigraphic de-
fects may widely exist within myocardium of SAH patients
without clinical, echocardiographic or laboratory evidence
of neurogenic stunned myocardium (NSM). The term
NSM has been introduced to describe myocardial injury
and dysfunction occurring after diverse types of acute
brain injury (including SAH) as a result of imbalance
of the autonomic nervous system [12]. The diagnosis
of NSM is based on a wide spectrum of cardiac abnormal-
ities, including LV systolic and diastolic dysfunction, myo-
cardial necrosis and arrhythmias [12]. In this respect, the
study by Prunet and coworkers widens the existing know-
ledge, suggesting that neurometabolic cardiac abnormal-
ities in acute SAH may represent a novel, subclinical type
of NSM – extending beyond the classic NSM, as the latter
has been defined until now.
One should point out that the presence of neurometa-
bolic cardiac abnormalities showed no association with
clinical outcomes in Prunet and colleagues’ study [1].
However, we previously showed that depressed LV sys-
tolic function in acute SAH may adversely influence out-
comes [13]. Our results were confirmed by more recent
data [14]. It is intriguing to speculate that a higher de-
gree of catecholamine-induced cardiotoxicity is probably
required for neurometabolic NSM to switch into mech-
anical NSM and acute heart failure [7,15]; however, this
is merely a hypothesis that needs to be studied.
In conclusion, the study by Prunet and colleagues un-
derlines two different aspects in SAH. First, alterations in
glucose metabolism, possibly neurogenic in origin, may
affect widely the myocardium during the acute phase of
SAH. Second, and more important, the study emphasizes
that prolonged and slowly reversible neurometabolicabnormalities may globally occur in SAH even when
conventional cardiac evaluation is negative for NSM.
The clinical impact of such neurometabolic shifts
may be greatly underestimated, as they are difficult
to diagnose in the clinical practice. Additional research,
including also hemodynamically unstable patients with
depressed LV function, is necessary to clarify further
the role of neurometabolic cardiac alterations in acute
SAH.
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